- Home
- NAMS vs CODI Comparison
NAMS vs CODI Comparison
Compare NAMS & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- CODI
- Stock Information
- Founded
- NAMS 2019
- CODI 2005
- Country
- NAMS Netherlands
- CODI United States
- Employees
- NAMS N/A
- CODI N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- CODI Home Furnishings
- Sector
- NAMS Health Care
- CODI Consumer Discretionary
- Exchange
- NAMS Nasdaq
- CODI Nasdaq
- Market Cap
- NAMS 1.4B
- CODI N/A
- IPO Year
- NAMS N/A
- CODI 2006
- Fundamental
- Price
- NAMS $19.03
- CODI $21.99
- Analyst Decision
- NAMS Strong Buy
- CODI Buy
- Analyst Count
- NAMS 6
- CODI 2
- Target Price
- NAMS $33.80
- CODI $26.50
- AVG Volume (30 Days)
- NAMS 243.4K
- CODI 213.4K
- Earning Date
- NAMS 01-01-0001
- CODI 10-30-2024
- Dividend Yield
- NAMS N/A
- CODI 4.54%
- EPS Growth
- NAMS N/A
- CODI N/A
- EPS
- NAMS N/A
- CODI 0.16
- Revenue
- NAMS $7,424,000.00
- CODI $2,154,939,000.00
- Revenue This Year
- NAMS N/A
- CODI $11.47
- Revenue Next Year
- NAMS N/A
- CODI $7.58
- P/E Ratio
- NAMS N/A
- CODI $139.62
- Revenue Growth
- NAMS N/A
- CODI 10.29
- 52 Week Low
- NAMS $5.63
- CODI $16.88
- 52 Week High
- NAMS $26.35
- CODI $25.07
- Technical
- Relative Strength Index (RSI)
- NAMS 69.87
- CODI 59.13
- Support Level
- NAMS $17.00
- CODI $20.53
- Resistance Level
- NAMS $19.41
- CODI $21.11
- Average True Range (ATR)
- NAMS 0.86
- CODI 0.39
- MACD
- NAMS 0.21
- CODI 0.02
- Stochastic Oscillator
- NAMS 90.26
- CODI 78.49
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.